In this Q&A, Marty Becker, DVM, Elite FFCP-V and Paul Bloom, DVM, DACVD, DABVP (Canine and Feline), Elite FFCP-III share ...

Sign up for the Morning Brief email newsletter to get weekday updates from The Weather Channel and our meteorologists.If you ...

Comment by Feb. 17 for your feedback to be reviewed by the guideline development workgroup.

Tapinarof, however, offers a potential solution by improving the skin barrier, reducing inflammation and relieving itch ...

AD, The most common inflammatory skin disorder worldwide, is a highly heterogeneous condition with current treatments that do ...

Boulder-based Enveda Biosciences, which uses machine learning to discover naturally occurring drug compounds, plans to begin testing ENV-294, its leading drug candidate developed to treat atopic ...

Data from a retrospective multicenter study, along with a review of previous trials, supported the real-world utility of ...

As temperatures drop, many people experience dry, red, and itchy skin, a condition that often worsens in winter.

Long-term lebrikizumab was effective for atopic dermatitis treatment in patients who did not have adequate response to short-term treatment.

Arcutis Biotherapeutics is going long with the latest push for its seborrheic dermatitis treatment Zoryve. | Arcutis ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Enrollment of Part A completed ahead of schedule and exceeded enrollment target with 123 patients enrolledPart A 16-week proof-of-concept data ...